| (210) | Number of the EPO application | 16721040 |
| (220) | Filing date of the EPO application | 2016.04.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 44/2019, 2019.10.30 |
| (110) | EPO patent number | 3288935 |
| (21) | Number of the application | e 2018 0229 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | AMERIKS Michael K., US;
RAVULA Suchitra, US;
SAVALL Bradley M., US;
SWANSON Devin M., US;
ZIFF Jeannie M., US;
SHIREMAN Brock T., US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | INDOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 209/34 (2006.01.01); C07D 401/04 (2006.01.01); C07D 401/10 (2006.01.01); C07D 403/10 (2006.01.01); C07D 403/12 (2006.01.01); C07D 405/12 (2006.01.01); C07D 413/10 (2006.01.01); C07D 417/12 (2006.01.01); A61P 23/00 (2006.01.01); A61P 25/00 (2006.01.01); A61P 25/06 (2006.01.01); A61P 25/16 (2006.01.01); A61P 25/18 (2006.01.01); A61P 25/24 (2006.01.01); A61P 25/28 (2006.01.01); A61P 31/18 (2006.01.01); A61P 37/00 (2006.01.01); A61K 31/404 (2006.01.01); A61K 31/4433 (2006.01.01); A61K 31/4439 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2018.04.30 |
| (30) | Priority | 201562154315 P, 2015.04.29, US |
| (86) | International application | PCT/US2016/029805, 2016.04.28 |
| (87) | International publication | WO 2016/176463, 2016.11.03 |